Skip to content

Bringing Precision Medicine to Market

  • June 10, 2019

When it comes to biopharmaceutical drug discovery and development, we live in an incredible time. The FDA has approved innovative medicines with differing approaches, platforms, technologies, and modalities. As we leverage new technologies, our strategies for drug discovery are leading to therapeutic diversity, which is rapidly becoming a complicated landscape for manufacturing teams.

In this eBook authored by Amit Bhatia, Anthony Reese, and Akhil Rachamadugu of Scimitar, Inc., learn how diverse therapies are creating complexity and how digital innovations are driving modernization in today’s biopharmaceutical landscape.

Topics covered:

  • Novel Technologies and Platforms
  • Every Patient is a “Batch”
  • What is Needed to Scale for Success?
  • Case Studies

 

RELATED NEWS

Beyond the Box: Laura Moffitt on Innovating Packaging Design at L'Oréal [Speaker Spotlight]

As the visionary Director of Packaging Design at L'Oréal, Laura Moffitt steers the global packaging initiatives for ...

by Anastasiia Romanenko

Directing SMEs Through European Regulations and Their Impact on Patient-Centric Medical Devices with Dr. Ewen Northwood [Speaker Spotlight]

In this Speaker Spotlight, Dr. Ewen Northwood delves into the challenges faced by SMEs in medical device development,...

by Devyn Smith

BIC CEO Gonzalve Bich: Igniting Creativity and Growth [Speaker Spotlight]

Gonzalve Bich is the Chief Executive Officer of BIC, where he leads the development and implementation of strategic...

by Anastasiia Romanenko